PHARMAGEND Trademark

Trademark Overview


On Monday, March 18, 2024, a trademark application was filed for PHARMAGEND with the United States Patent and Trademark Office. The USPTO has given the PHARMAGEND trademark a serial number of 79397084. The federal status of this trademark filing is REGISTERED as of Tuesday, March 11, 2025. This trademark is owned by PharmaGend Global Medical Services Pte Ltd. The PHARMAGEND trademark is filed in the Advertising, Business and Retail Services, Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom assembling of materials for others, namely, multi-layer coated tablets, liquid filled hard gelatin capsules, bottle filling activities; providing information relating to material treatment; processing of metal surfaces using precision grinding techniques; irradiation of food; cryopreservation services; food and drink processing for others; processing of chemicals; sorting of waste and recyclable material; bookbinding; grinding

Immunological products for intravenous injections, namely for immune system support, such as vaccines, monoclonal antibodies (mAbs), Cytokines/Cytokine Inhibitors; tablets for medicines specifically diuretic, anti-fungal, digestive disorders, anti-inflammatory, antidiabetic, dementia tablets for treating common infections and chronic diseases; drinking water fused with electrolytes, salts, Hemodialysis solution, suitable for rehydration and maintenance therapy for medical purposes; medicinal ointments for treating skin conditions, such as dermatitis, wounds, or burns, offering antiseptic and healing properties; gelatin capsules sold empty for pharmaceuticals; slimming pills; medicines for human purposes for treating various ailments ranging from cough and cold medicines to cardiac disease; nutraceutical preparations for therapeutic or medical purposes for treating digestive disorders, vitamin deficiency, therapeutic dosage of vitamins; biochemical medicines for treating metabolic disor...

Import-export agency services; business management consultancy; outsourcing services; business research; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies

Bases being chemical preparations of pharmaceutical drug product formulation, manufacturing, packing, testing and release to market; salts being chemical preparations for improved therapeutic actions, additional indication, drug product stability enhancement and bioavailability improvement in pharmaceutical products; cellulose derivatives being chemical preparations for use as excipients in drug formulation, providing controlled release and delayed release of drug enhancing bioavailability of drug product; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; animal extracts in the nature of from bovine source for use in pharmaceutical and nutraceutical manufacturing, particularly in dietary supplements and therapeutic drug products as well as nutritional products for the food industry; biological preparations for use in industry and science, other than fo...

Technological research in the field of formulation development, scale-up batches, formulation refinement, drug delivery systems, and optimization of production processes; conducting technical project studies, namely, bioequivalence studies, clinical trial study design and regulatory compliance research in the pharmaceutical field; scientific laboratory services; providing scientific information, advice and consultancy relating to carbon offsetting; quality control for others; industrial inspection serialization of products, medical devices; quality assessment of pharmaceutical manufacturing processes, process validation, focusing on batch consistency, contamination control, impurity profiling and GMP compliance; biological research; medical and scientific research, namely, conducting clinical trials for others; medical research
pharmagend

General Information


Serial Number79397084
Word MarkPHARMAGEND
Filing DateMonday, March 18, 2024
Status700 - REGISTERED
Status DateTuesday, March 11, 2025
Registration Number7717933
Registration DateTuesday, March 11, 2025
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 21, 2025

Trademark Statements


Goods and ServicesCustom assembling of materials for others, namely, multi-layer coated tablets, liquid filled hard gelatin capsules, bottle filling activities; providing information relating to material treatment; processing of metal surfaces using precision grinding techniques; irradiation of food; cryopreservation services; food and drink processing for others; processing of chemicals; sorting of waste and recyclable material; bookbinding; grinding
Goods and ServicesImmunological products for intravenous injections, namely for immune system support, such as vaccines, monoclonal antibodies (mAbs), Cytokines/Cytokine Inhibitors; tablets for medicines specifically diuretic, anti-fungal, digestive disorders, anti-inflammatory, antidiabetic, dementia tablets for treating common infections and chronic diseases; drinking water fused with electrolytes, salts, Hemodialysis solution, suitable for rehydration and maintenance therapy for medical purposes; medicinal ointments for treating skin conditions, such as dermatitis, wounds, or burns, offering antiseptic and healing properties; gelatin capsules sold empty for pharmaceuticals; slimming pills; medicines for human purposes for treating various ailments ranging from cough and cold medicines to cardiac disease; nutraceutical preparations for therapeutic or medical purposes for treating digestive disorders, vitamin deficiency, therapeutic dosage of vitamins; biochemical medicines for treating metabolic disorders, hormonal imbalances, autoimmune diseases, and rare genetic conditions, such as enzyme replacement therapies, peptide-based drugs, and nucleotide-based therapies; pharmaceutical preparations for treating heart diseases, asthma, obesity, diabetes, hypertension
Goods and ServicesImport-export agency services; business management consultancy; outsourcing services; business research; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies
Goods and ServicesBases being chemical preparations of pharmaceutical drug product formulation, manufacturing, packing, testing and release to market; salts being chemical preparations for improved therapeutic actions, additional indication, drug product stability enhancement and bioavailability improvement in pharmaceutical products; cellulose derivatives being chemical preparations for use as excipients in drug formulation, providing controlled release and delayed release of drug enhancing bioavailability of drug product; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; animal extracts in the nature of from bovine source for use in pharmaceutical and nutraceutical manufacturing, particularly in dietary supplements and therapeutic drug products as well as nutritional products for the food industry; biological preparations for use in industry and science, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; plant extracts, other than essential oils, for use in the manufacture of pharmaceuticals; plant extracts, other than essential oils, for use in the manufacture of cosmetics
Goods and ServicesTechnological research in the field of formulation development, scale-up batches, formulation refinement, drug delivery systems, and optimization of production processes; conducting technical project studies, namely, bioequivalence studies, clinical trial study design and regulatory compliance research in the pharmaceutical field; scientific laboratory services; providing scientific information, advice and consultancy relating to carbon offsetting; quality control for others; industrial inspection serialization of products, medical devices; quality assessment of pharmaceutical manufacturing processes, process validation, focusing on batch consistency, contamination control, impurity profiling and GMP compliance; biological research; medical and scientific research, namely, conducting clinical trials for others; medical research

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharmaGend Global Medical Services Pte Ltd
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Party NamePharmaGend Global Medical Services Pte Ltd
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Party NamePharmaGend Global Medical Services Pte Ltd
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Trademark Events


Event DateEvent Description
Thursday, June 6, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, June 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 10, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, September 25, 2024ASSIGNED TO EXAMINER
Friday, September 27, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 2, 2024REFUSAL PROCESSED BY MPU
Wednesday, October 2, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 26, 2024NON-FINAL ACTION WRITTEN
Sunday, December 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, December 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 19, 2024REFUSAL PROCESSED BY IB
Sunday, December 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 10, 2025WITHDRAWN FROM ISSUE - OG REVIEW QUERY
Wednesday, January 15, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 21, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 21, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 11, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, March 11, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, June 12, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB